(PDF) Utilization of Bevacizumab Among Medicare Patients

Utilization of Bevacizumab Among Medicare Patients With Colorectal Cancer Receiving Chemotherapy

Value in Health - United Kingdom

doi 10.1016/j.jval.2013.03.746

Full Text

Abstract

Available in full text

Categories

Occupational Health

Date

May 1, 2013

Authors

Publisher

Elsevier BV

Related search

Adverse Events Associated With Bevacizumab and Chemotherapy in Older Patients With Metastatic Colorectal Cancer

Clinical Colorectal Cancer

Gastroenterology

English

Hypertension and Overall Survival in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Containing Chemotherapy

British Journal of Cancer

Cancer Research

English

Perioperative Chemotherapy With or Without Bevacizumab in Patients With Metastatic Colorectal Cancer Undergoing Liver Resection

Clinical Colorectal Cancer

Gastroenterology

English

Tumoral Cavitation in Colorectal Cancer Patients With Unresectable Lung Metastasis Treated With Bevacizumab and Chemotherapy

Journal of Cancer Research and Clinical Oncology

Cancer Research

English

Effect and Safety of Bevacizumab-Containing Chemotherapy Treatment in Chinese Patients With Metastatic Colorectal Cancer

OncoTargets and Therapy

English

Adjuvant Systemic Chemotherapy With or Without Bevacizumab in Patients With Resected Pulmonary Metastases From Colorectal Cancer.

Journal of Clinical Oncology

Cancer Research

English

Adjuvant Systemic Chemotherapy With or Without Bevacizumab in Patients With Resected Pulmonary Metastases From Colorectal Cancer

Thoracic Cancer

Respiratory Medicine

English

Biomarker Signatures Correlate With Clinical Outcome in Refractory Metastatic Colorectal Cancer Patients Receiving Bevacizumab and Everolimus

Molecular Cancer Therapeutics

Cancer Research

English

Anticoagulant Therapy for Venous Thromboembolism Detected by Doppler Ultrasound in Patients With Metastatic Colorectal Cancer Receiving Bevacizumab

OncoTargets and Therapy

English